Survival in 31 670 patients with thin melanomas - a Swedish population-based study.

CONCLUSION: Long-term MSS was confirmed excellent for patients with thin CMMs in Sweden. Although we could show a decreased MSS for patients with 0·7 mm and above, the long-term survival and in addition a very favourable CMSS for those patients, do not support more extended follow-up programs than current recommendations in Sweden. PMID: 32133615 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32133615?dopt=Abstract

Source: The British Journal of Dermatology - March 3, 2020 Category: Dermatology Authors: Isaksson K, Mikiver R, Eriksson H, Lapins J, Nielsen K, Ingvar C, Lyth J Tags: Br J Dermatol Source Type: research